In brain tumors, various findings demonstrated that in addition to its key role as a core regulator of cellular glycolysis, PKM2 holds a critical tumorigenic function as a protein kinase in the nucleus through its involvement in gene transcription and as a transcriptional co-activator of oncogenic signals24. This evidence concerns the gene WEE1 and brain neoplasm.